Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.51 +0.01 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $1.37 | |||
| Open | $0.50 | 52 Week Low | $0.24 | |||
| Day High | $0.52 | P/E | N/A | |||
| Day Low | $0.49 | EPS | $0.00 | |||
| Volume | 771,671 | |||||
